Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis

被引:78
作者
Ohmori, H
Makita, Y
Funamizu, M
Hirooka, K
Hosoi, T
Orimo, H
Suzuki, T
Ikari, K
Nakajima, T
Inoue, I
Hata, A
机构
[1] Asahikawa Med Coll, Dept Publ Hlth, Asahikawa, Hokkaido 0788510, Japan
[2] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan
[3] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan
[4] Univ Tokyo, Inst Med Sci, Div Genet Diag, Tokyo, Japan
关键词
osteoprotegerin; osteoporosis; single-nucleotide polymorphism; BMD; sib pair analysis;
D O I
10.1007/s100380200058
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Osteoprotegerin (OPG), a secreted glycoprotein and a member of the tumor necrosis factor receptor superfamily, is considered to play an important role in the regulation of bone resorption by modifying osteoclast differentiation. Overexpression of OPG in mice has been reported to result in osteopetrosis, whereas targeted disruption of OPG in mice has been associated with osteoporosis. Accordingly, OPG could be a strong candidate gene for susceptibility to human osteoporosis. Here, we analyzed whether OPG is involved in the etiology of osteoporosis using both linkage and association analyses. We recruited 164 sib pairs in Gunma prefecture, which is located in the central part of Honshu (mainland Japan), for a linkage study, and 394 postmenopausal women in Akita prefecture, which is in the northern part of Honshu, for an association study. We identified two microsatellite polymorphisms in the linkage study, and six single-nucleotide polymorphisms (SNPs) in the OPG region for the association study. Although, no evidence of significant linkage between OPG and osteoporosis was found, a possible association of one SNP, located in the promoter region of the gene, was identified. A haplotype analysis with the six SNPs revealed that four major haplotypes account for 71% of the alleles in the Japanese population.
引用
收藏
页码:400 / 406
页数:7
相关论文
共 29 条
  • [1] Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
    Browner, WS
    Lui, LY
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 631 - 637
  • [2] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [3] den Dunnen JT, 2000, HUM MUTAT, V15, P7
  • [4] First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q
    Devoto, M
    Shimoya, K
    Caminis, J
    Ott, J
    Tenenhouse, A
    Whyte, MP
    Sereda, L
    Hall, S
    Considine, E
    Williams, CJ
    Tromp, G
    Kuivaniemi, H
    Ala-Kokko, L
    Prockop, DJ
    Spotila, LD
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (02) : 151 - 157
  • [5] Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO
  • [6] 2-G
  • [7] The genetics of osteoporosis:: 'complexities and difficulties'
    Giguère, Y
    Rousseau, F
    [J]. CLINICAL GENETICS, 2000, 57 (03) : 161 - 169
  • [8] Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene
    Grant, SFA
    Reid, DM
    Blake, G
    Herd, R
    Fogelman, I
    Ralston, SH
    [J]. NATURE GENETICS, 1996, 14 (02) : 203 - 205
  • [9] HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622
  • [10] Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism
    Hofbauer, LC
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 141 (03) : 195 - 210